#gplc

1 article

A wide, editorial-style photograph of a lone cyclist's legs and torso mid-sprint on a stationary indoor bike in a bright, minimalist performance studio. The scene is shot from a low three-quarter angle with shallow depth of field. The cyclist wears matte charcoal shorts and a fitted sage-green top, with a subtle sheen of sweat catching soft window light. Their hands grip the handlebars and the pedals are caught in a slight motion blur, which conveys explosive effort.

In the foreground, slightly out of focus on a pale oak side table, sit a small matte white scoop and a clear glass of water. Next to them is a little ceramic dish holding a few off-white capsules and a pinch of fine white powder. A folded linen towel and a slim stopwatch rest nearby. The stopwatch face is softly legible, hinting at timed sprint intervals.

The background is warm cream concrete and pale wood, with tall windows casting long diagonal shafts of golden morning light across the floor. Faint dust motes drift in the light. On the wall behind, a clean, abstract line graph is painted in muted terracotta and deep teal. It shows one line rising in steps like five sprint bouts and another line gently falling, a subtle visual nod to power up and lactate down. The graph is minimal and stylized, with no readable numbers or text.

The color palette is earthy and modern: sage green, terracotta, warm cream, soft charcoal, and touches of natural wood. The lighting is soft and directional with gentle highlights and natural shadows. The overall look is calm, refined, and contemporary, like a premium wellness and sports science magazine cover. The composition follows the rule of thirds, with the cyclist on the right and open negative space on the left for a headline. The image is crisp, grainy in a subtle film-like way, and free of any futuristic or sci-fi elements.

このカルニチン形態がスプリントパワーを最大15%向上させ、乳酸を低減

BY DR. GYMBRO · 2026年10月23日

2009 年のクロスオーバー研究で、グリシン・プロピオニル‑L‑カルニチン（GPLC）を 4.5 g 投与しただけで、5 回の全力サイクリングスプリントにおける最大パワーが 2.6 %〜15 % 向上し、運動後 14 分の血中乳酸は 16.2 % 低下したことが明らかになった。本稿では GPLC と一般的な L‑カルニチン、ALCAR の違い、NO 仮説、適応者・不適応者、用量・タイミング、エビデンスの限界を解説する。